Director of the Center for Drug Evaluation and Research at FDA, Dr Janet Woodcock previously served as FDA Deputy Commissioner and Chief Medical Officer.
Janet Woodcock has close interactions with diverse constituencies, including the clinical and scientific communities, members of Congress and the Administration, national media, patient and consumer advocacy groups, the international drug regulatory community, the regulated industry, and representatives of the Federal and State agencies. She frequently appears in or is quoted by the national media and has testified repeatedly before Congress.
Woodcock has led many cross-Agency initiatives while at FDA. She introduced the concept of pharmaceutical risk management in 2000 as a new approach to drug safety. She has led the “Pharmaceutical Quality for the 21st Century Initiative” since 2002.
Woodcock has earned numerous awards, including a Presidential Rank Meritorious Executive Award, the Nathan Davis Award from the American Medical Association (1999), the Roger W. Jones Award for Executive Leadership from American University (2000) the Public Health Leadership Award (2004) from the National Organization for Rare Disorders (NORD), the VIDA Award from The National Alliance for Hispanic Health (2005), the Leadership Award in Personalized Medicine from the Personalized Medicine Coalition (2005), the Public Service Award from the American Association for Cancer Research (2006), the “indispensable person of the year award” from the Alliance for Aging Research (2007), the Distinguished Service and Leadership Award from the Food and Drug Law Institute (2008), the Distinguished Career Award from the Drug Information Association (2008) and the Neal Prize for Innovation in Drug Development from the ASCPT (2009). She has also received three HHS Secretary’s Distinguished Service Awards and the HHS Asian-Pacific Network achievement award (2001) and six FDA Commissioner’s Special Citations. She has authored over 60 publications.